Montag & Associates’s Veracyte VCYT Stock Holding History

Montag & Associates’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.33K	Buy	41 +6	+17%	+$222	﹤0.01%	878
2025 Q4	$1.49K	Sell	35 -4	-10%	-$161	﹤0.01%	892
2025 Q3	$1.35K	Buy	39 +3	+8%	+$86	﹤0.01%	971
2025 Q2	$985	Hold	36	–	–	﹤0.01%	913
2025 Q1	$1.08K	Buy	36 +4	+13%	+$152	﹤0.01%	944
2024 Q4	$1.27K	Hold	32	–	–	﹤0.01%	926
2024 Q3	$1.09K	Hold	32	–	–	﹤0.01%	971
2024 Q2	$697	Hold	32	–	–	﹤0.01%	959
2024 Q1	$713	Buy	+32	New	+$781	﹤0.01%	954

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Montag & Associates's VCYT Position: Q1 2026 in Review

Montag & Associates increased its Veracyte (VCYT) stake by 17% in Q1 2026, buying an estimated $222 and bringing the position to 41 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Montag & Associates first reported a position in VCYT in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.49K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Montag & Associates held 41 shares of Veracyte worth $1.33K as of Q1 2026.
Montag & Associates bought 6 Veracyte shares in Q1 2026, an estimated $222.
Veracyte made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #878 holding.
Montag & Associates first reported a position in Veracyte in Q1 2024 and has held it in 9 quarters since.
Montag & Associates's Veracyte position peaked at $1.49K in Q4 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.